abstract |
Disclosed herein are diagnostic markers CTHRCl, CANP and KIAA0101, which are overexpressed specifically in breast or colorectal cancer. A method for diagnosing the cancer by- detecting the markers, and a method for preventing or treating by inhibiting the expression and activity of the markers are also disclosed. |